BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11018722)

  • 1. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
    Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
    Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
    Kobayashi H; Gotoh J; Terao T
    Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
    Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
    J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review].
    Kobayashi H
    Hum Cell; 2001 Sep; 14(3):233-6. PubMed ID: 11774742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
    Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
    J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
    Kobayashi H; Sugino D; Terao T
    Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade.
    Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Mar; 278(10):7790-9. PubMed ID: 12496270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.
    Kobayashi H; Fujie M; Shinohara H; Ohi H; Sugimura M; Terao T
    Int J Cancer; 1994 May; 57(3):378-84. PubMed ID: 8168999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
    Kole KL; Gyetko MR; Simpson RU; Sitrin RG
    Biochem Pharmacol; 1991 Feb; 41(4):585-91. PubMed ID: 1900005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
    Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
    J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Terao T
    Biochim Biophys Acta; 2001 May; 1547(1):26-36. PubMed ID: 11343788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
    Wang Y; Dang J; Liang X; Doe WF
    Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
    Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
    Reuning U; Wilhelm O; Nishiguchi T; Guerrini L; Blasi F; Graeff H; Schmitt M
    Nucleic Acids Res; 1995 Oct; 23(19):3887-93. PubMed ID: 7479032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.